Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-driven, open-label, non-randomized, uncontrolled, dose-escalating Phase I/II-trial

Benutzer: Gast

Dokumenttyp:: Zeitschriftenaufsatz
Autor(en):: Buhmann, Raymund; Michael, Stanglmaier; Juergen, Hess; Horst, Lindhofer; Peschel, Christian; Kolb, Hans-Jochem
Titel:: Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-driven, open-label, non-randomized, uncontrolled, dose-escalating Phase I/II-trial
Zeitschriftentitel:: Journal of Translational Medicine
Jahr:: 2013
Band / Volume:: 11
Heft / Issue:: 1
Volltext / DOI:: doi:10.1186/1479-5876-11-160
Verlag / Institution:: Springer Nature
E-ISSN:: 1479-5876
Publikationsdatum:: 02.07.2013
BibTeX

Vorkommen: